H-BETA-ALA-GLY-OH
- CAS NO.:2672-88-0
- Empirical Formula: C5H10N2O3
- Molecular Weight: 146.14
- MDL number: MFCD00025611
- SAFETY DATA SHEET (SDS)
What is H-BETA-ALA-GLY-OH?
Definition
ChEBI: A dipeptide formed from beta-alanine and glycine residues.
Properties of H-BETA-ALA-GLY-OH
| Melting point: | 230 °C |
| Boiling point: | 448.1±30.0 °C(Predicted) |
| Density | 1.267±0.06 g/cm3(Predicted) |
| storage temp. | -15°C |
| pka | 3.29±0.10(Predicted) |
Safety information for H-BETA-ALA-GLY-OH
Computed Descriptors for H-BETA-ALA-GLY-OH
New Products
1-Chloro-4-Methyl-2-Nitrobenzene 4-Bromo-2-chlorobenzonitrile 3-(4-morpholinophenylamino)-5-amino-1H-pyrazole-4-carbonitrile 1,3-Diethyl-1,3-Diphenylurea Methyl 2-methylquinoline-6-carboxylate 2-((4-morpholinophenylamino) (methylthio) methylene) malononitrile Stanozolol Ethinyl Estradiol Clarithromycin Boldenone Progesterone Vitamin D3 vegan 2,4-Difluoro-5-nitrobenzoicacid Methyl 2-oxo-2,3-dihydrobenzo[d]oxazole-7-carboxylate 3-Hydroxy-4-nitrobromobenzene 4-(2-Aminoethyl)-7-hydroxy-2H-chromoen-2-one 2-Ethyl-1,4-diaminobenzene 2-Ethylhexyl 4-aminobenzoate 2-(2-chloropyrimidin-4-yl)acetic acid Boc-Arg-OH HCl H2O Boc-His(Boc)-OH (4-(methylamino)phenyl)methanesulfonic acid 2-CTC Resin 2-(4-(tert-butoxycarbonyl)piperazin-2-yl)acetic acidRelated products of tetrahydrofuran








You may like
-
BETA-ALANYLGLYCINE CAS 2672-88-0View Details
2672-88-0 -
N,N-Dicyclohexylcarbodiimide(DCC) 99%View Details
538-75-0 -
Gabapentin EP Impurity B 133481-09-1 >95%View Details
133481-09-1 -
Boc-L-Ala-OH >98%View Details
15761-38-3 -
2-Methoxyphenothiazine >98%View Details
1771-18-2 -
4-Chloropyrrolo[2,3-d]-pyrimidine 98%View Details
3680-69-1 -
31972-52-8 >95%View Details
31972-52-8 -
6296-42-0 2-Chloroethylurea 99%View Details
6296-42-0
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
